name,category,terms2,4-dienoyl CoA reductase 2, peroxisomal,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
2,4-dienoyl CoA reductase 2, peroxisomal,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001128$peroxisome, 790001162$phosphoprotein]
2,4-dienoyl CoA reductase 2, peroxisomal,UP_SEQ_FEATURE[850037909$chain:Peroxisomal 2,4-dienoyl-CoA reductase, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850117578$short sequence motif:Microbody targeting signal, 850118574$splice variant]
4-aminobutyrate aminotransferase,INTERPRO[450004121$IPR004631:4-aminobutyrate aminotransferase, eukaryotic, 450005262$IPR005814:Aminotransferase class-III, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1]
4-aminobutyrate aminotransferase,KEGG_PATHWAY[470038745$hsa00250:Alanine, aspartate and glutamate metabolism, 470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038758$hsa00410:beta-Alanine metabolism, 470038789$hsa00640:Propanoate metabolism, 470038790$hsa00650:Butanoate metabolism]
4-aminobutyrate aminotransferase,OMIM_DISEASE[520001955$GABA-transaminase deficiency]
4-aminobutyrate aminotransferase,PIR_SUPERFAMILY[630000621$PIRSF000521:4-aminobutyrate transaminase]
4-aminobutyrate aminotransferase,SP_PIR_KEYWORDS[790000012$acetylation, 790000070$Aminotransferase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000969$mitochondrion, 790001025$neurotransmitter degradation, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase, 790001550$transit peptide]
4-aminobutyrate aminotransferase,UP_SEQ_FEATURE[850001842$chain:4-aminobutyrate aminotransferase, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
B-cell scaffold protein with ankyrin repeats 1,INTERPRO[450016208$IPR017893:DBB domain]
B-cell scaffold protein with ankyrin repeats 1,OMIM_DISEASE[520001949$Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus, 520002051$Genome-wide association study targeting systemic lupus erythematosus., 520004787$Systemic lupus erythmatosus, association with]
B-cell scaffold protein with ankyrin repeats 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000153$b-cell activation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001478$systemic lupus erythematosus]
B-cell scaffold protein with ankyrin repeats 1,UP_SEQ_FEATURE[850007064$chain:B-cell scaffold protein with ankyrin repeats, 850103499$domain:DBB, 850112452$region of interest:Interaction with ITPR2, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
C-type lectin domain family 1, member B,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 1, member B,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 1, member B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 1, member B,UP_SEQ_FEATURE[850008703$chain:C-type lectin domain family 1 member B, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD2 (cytoplasmic tail) binding protein 2,INTERPRO[450002786$IPR003169:GYF]
CD2 (cytoplasmic tail) binding protein 2,PIR_SUPERFAMILY[630029529$PIRSF037959:CD2 antigen cytoplasmic tail-binding protein 2]
CD2 (cytoplasmic tail) binding protein 2,SMART[760000390$SM00444:GYF]
CD2 (cytoplasmic tail) binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
CD2 (cytoplasmic tail) binding protein 2,UP_SEQ_FEATURE[850010131$chain:CD2 antigen cytoplasmic tail-binding protein 2, 850104094$domain:GYF, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
CDC42 small effector 1,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 1,SMART[760000256$SM00285:PBD]
CDC42 small effector 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 1,UP_SEQ_FEATURE[850010188$chain:CDC42 small effector protein 1, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850113403$region of interest:Mediates phosphoinositide-binding, 850118574$splice variant]
D4, zinc and double PHD fingers, family 3,COG_ONTOLOGY[90000118$Transcription / Cell division and chromosome partitioning]
D4, zinc and double PHD fingers, family 3,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
D4, zinc and double PHD fingers, family 3,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000323$SM00355:ZnF_C2H2]
D4, zinc and double PHD fingers, family 3,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000937$metal-binding, 790001016$neurogenesis, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
D4, zinc and double PHD fingers, family 3,UP_SEQ_FEATURE[850102006$chain:Zinc finger protein DPF3, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
F-box and leucine-rich repeat protein 12,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box and leucine-rich repeat protein 12,SMART[760000228$SM00256:FBOX]
F-box and leucine-rich repeat protein 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 12,UP_SEQ_FEATURE[850018786$chain:F-box/LRR-repeat protein 12, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850118574$splice variant]
FOS-like antigen 1,BIOCARTA[30000250$h_ranklPathway:Bone Remodelling]
FOS-like antigen 1,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
FOS-like antigen 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
FOS-like antigen 1,PIR_SUPERFAMILY[630001865$PIRSF001719:fos transforming protein]
FOS-like antigen 1,SMART[760000306$SM00338:BRLZ]
FOS-like antigen 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus]
FOS-like antigen 1,UP_SEQ_FEATURE[850019993$chain:Fos-related antigen 1, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper]
FOS-like antigen 2,BIOCARTA[30000250$h_ranklPathway:Bone Remodelling]
FOS-like antigen 2,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
FOS-like antigen 2,PIR_SUPERFAMILY[630001865$PIRSF001719:fos transforming protein]
FOS-like antigen 2,SMART[760000306$SM00338:BRLZ]
FOS-like antigen 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein]
FOS-like antigen 2,UP_SEQ_FEATURE[850019994$chain:Fos-related antigen 2, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850106258$modified residue]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,INTERPRO[450000534$IPR000626:Ubiquitin, 450006249$IPR006846:Ribosomal protein S30, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup, 450018186$IPR019956:Ubiquitin subgroup]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,PIR_SUPERFAMILY[630002173$PIRSF002034:ubiquitin, 630002359$PIRSF002227:ribosomal protein S30e]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,SMART[760000186$SM00213:UBQ]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001212$polymorphism, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,UP_SEQ_FEATURE[850002053$chain:40S ribosomal protein S30, 850068144$chain:Ubiquitin-like protein FUBI, 850117295$sequence variant]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,INTERPRO[450014108$IPR015672:G-protein coupled receptor 89-related]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,PIR_SUPERFAMILY[630011150$PIRSF013287:uncharacterized conserved protein]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,UP_SEQ_FEATURE[850046312$chain:Protein GPR89, 850053876$chain:Putative protein GPR89C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
G protein-coupled receptor, family C, group 5, member A,INTERPRO[450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
G protein-coupled receptor, family C, group 5, member A,PIR_SUPERFAMILY[630030193$PIRSF038691:retinoic acid-induced G protein-coupled receptors]
G protein-coupled receptor, family C, group 5, member A,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor, family C, group 5, member A,UP_SEQ_FEATURE[850057425$chain:Retinoic acid-induced protein 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
